Dr Joel L Morgan, MD | |
3541 N Crossing Cir, Valdosta, GA 31602-1019 | |
(229) 244-4200 | |
(229) 244-4995 |
Full Name | Dr Joel L Morgan |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 37 Years |
Location | 3541 N Crossing Cir, Valdosta, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558360784 | NPI | - | NPPES |
00495943E | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 031295 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
South Georgia Medical Center | Valdosta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Valdosta Psychiatric Associates, Llc | 6305832650 | 5 |
Dmc Physician Group Llc | 8628296845 | 21 |
News Archive
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
Incontinence is typically a condition associated with adults; however, many children also struggle with incontinence - bladder, bowel or both. In order to help these children, doctors at Nationwide Children's Hospital have turned to a device, typically used in adult patients, to help manage children with chronic incontinence.
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
› Verified 8 days ago
Entity Name | Valdosta Psychiatric Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336282144 PECOS PAC ID: 6305832650 Enrollment ID: O20040422000175 |
News Archive
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
Incontinence is typically a condition associated with adults; however, many children also struggle with incontinence - bladder, bowel or both. In order to help these children, doctors at Nationwide Children's Hospital have turned to a device, typically used in adult patients, to help manage children with chronic incontinence.
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
› Verified 8 days ago
Entity Name | Dmc Physician Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124430020 PECOS PAC ID: 8628296845 Enrollment ID: O20140902000773 |
News Archive
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
Incontinence is typically a condition associated with adults; however, many children also struggle with incontinence - bladder, bowel or both. In order to help these children, doctors at Nationwide Children's Hospital have turned to a device, typically used in adult patients, to help manage children with chronic incontinence.
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joel L Morgan, MD Po Box 3229, Valdosta, GA 31604-3229 Ph: (229) 244-4200 | Dr Joel L Morgan, MD 3541 N Crossing Cir, Valdosta, GA 31602-1019 Ph: (229) 244-4200 |
News Archive
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
Incontinence is typically a condition associated with adults; however, many children also struggle with incontinence - bladder, bowel or both. In order to help these children, doctors at Nationwide Children's Hospital have turned to a device, typically used in adult patients, to help manage children with chronic incontinence.
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
› Verified 8 days ago
Mahmood Sayied Eisa, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4274 N Valdosta Rd, Valdosta, GA 31602 Phone: 229-242-1234 Fax: 229-247-8110 | |
Sheri L Swader, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 101f W Northside Dr, Valdosta, GA 31602 Phone: 229-262-1981 Fax: 229-375-0392 | |
Stephanie S Gee, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2410 Bemiss Rd Ste B, Valdosta, GA 31602 Phone: 229-249-8188 Fax: 229-219-8511 | |
Dr. Bipin R Patel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4274 N Valdosta Rd, Valdosta, GA 31602 Phone: 229-242-1234 Fax: 229-247-8110 | |
Dr. Wendy Liana Vandemark, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2109 N Patterson St Ste B, Valdosta, GA 31602 Phone: 229-232-4833 Fax: 877-343-0538 | |
Bhavesh A Patel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2704 N Oak St, Building B-3, Valdosta, GA 31602 Phone: 229-257-0100 Fax: 229-257-0050 |